Saltar al contenido principal
Elsevier

A New History of Vaccines for Infectious Diseases

Immunization - Chance and Necessity

  • 1 Edición - 4 de enero de 2022
  • Última edición
  • Autor: Anthony R. Rees
  • Idioma: Inglés

A New History of Vaccines for Infectious Diseases: Immunization - Chance and Necessity covers the developments of vaccines and how they have obliterated many fatal diseases and in… Leer más

Descripción

A New History of Vaccines for Infectious Diseases: Immunization - Chance and Necessity covers the developments of vaccines and how they have obliterated many fatal diseases and infections over time. The book treads a neutral path but does not avoid discussion. As uncertainty in the outcome of vaccination can only be determined by experiment, the path to vaccine development has been scientifically complex because the immune system and the manner in which humans respond to infection is variable and complex. Finally, the book describes the risks and benefits of vaccines in a visibly objective manner.

Puntos claves

  • 2023 PROSE Awards - Winner: Finalist: History of Science, Medicine, and Technology: Association of American Publishers
  • Gives an objective description of the science behind vaccine discovery
  • Presents awareness and discussions on controversies, both past and present
  • Provides historical context to the scientific aspects of immunization, including what worked, what didn't, and why
  • Written by a scientist with no ‘vested interest’ in vaccine development
  • Clears up many misunderstandings for today’s vaccination policies

De interès para

Scientific researchers, graduate and postgraduate students in immunology, medicine, biological sciences and history of science, medical profession, science teachers

Índice

1. Infectious disease protection: A historical documentary

2. The scourge of smallpox and the genius of an 18th century country doctor

3. Smallpox vaccination in the 19th century: Obstinacy versus pragmatism

4. The biological origins of infection unveiled

5. Cholera, typhoid, paratyphoid, and plague: A cautious start to a vaccine revolution

6. Diphtheria and tetanus: The discovery of passive immunization

7. The tuberculosis roller coaster: Vaccines and antibiotics

8. The discovery of viruses provides epic challenges for vaccinology

9. Yellow fever, Dengue and Zika: Tropical viral diseases and vaccine development

10. Influenza virus: A scientific and evolutionary chameleon

11. The Polio virus: Its conquest amid inflamed debate and controversy

12. Measles, Mumps and Rubella: Vaccination, mortality, and uncertainty

13. Ebola and Marburg viruses: Modern solutions to life-threatening infections

14. Corona viruses: Immunological challenges of the ‘new’ infections

15. Vaccines are not always perfect: Adverse effects and their clinical impact

16. Vaccination and freedom of choice: The individual and the population

17. Scientific Glossary

Reseñas

"A New History of Vaccines by Anthony Rees is a well-written and encyclopedic work that is very timely, in that vaccines are much in the public consciousness and a detailed modern history is lacking. It is comprehensive but written clearly and with great insight into how vaccines are developed and used to prevent disease and death throughout the world."—Stanley A Plotkin, MD, Emeritus Professor of Pediatrics, University of Pennsylvania

Detalles del producto

  • Edición: 1
  • Última edición
  • Publicado: 10 de enero de 2022
  • Idioma: Inglés

Sobre el autor

AR

Anthony R. Rees

Anthony Robert Rees, educated at the University of Oxford (MSc, MA, DPhil), has had a distinguished academic and research career spanning over 30 years in receptor biology and molecular immunology. He served as a Lecturer in Molecular Biophysics at Oxford (1980-90) before becoming Professor of Biochemistry and Head of the School of Biology & Biochemistry at the University of Bath (1990-97). He was honored with an Emeritus Professorship in 2003 and a Doctor of Science Honoris Causa in 2009 by the University of Bath. Rees co-founded the Oxford University spin-out, Oxford Molecular plc, in 1989, which floated on the LSE in 1994. He held senior executive roles in French and Swedish biotech companies and was a founding board member of the Austrian antibody biotech company F-star. An expert in antibody repertoire theory, he is a consultant in immunology and a member of the American Association for the History of Medicine.
Afiliaciones y experiencia
Emeritus Professor of Biochemistry & Author, Stockholm, Sweden

Ver libro en ScienceDirect

Lee A New History of Vaccines for Infectious Diseases en ScienceDirect